The ABVD regimen is most commonly prescribed for patients diagnosed with Hodgkin Lymphoma. Eligibility for this treatment is determined by several factors, including the stage of cancer, patient's overall health, and the presence of any other underlying conditions. Oncologists will evaluate these factors through diagnostic tests and patient history before recommending ABVD.
